CRKL and chronic myelogenous leukemia, BCR-ABL1 positive: As Crkl is a prominent substrate of BCR/ABL oncoprotein in CML and binds to BCR/ABL, we detected the expression of phospho-Crkl in the neutrophils by immunofluorescence.